Copyright
©The Author(s) 2020.
World J Cardiol. Nov 26, 2020; 12(11): 513-525
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.513
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.513
Treatment strategy | All (n = 105) | Pathology | P value | |
STEMI (n = 37) | NSTEMI (n = 68) | |||
Acute management | ||||
Coronary angiography | 76 (72.4) | 34 (91.9) | 42 (61.8) | 0.001 |
Coronary revascularization | 60 (57.1) | 34 (91.9) | 26 (38.2) | < 0.001 |
Elective medical therapy | 29 (27.6) | 3 (8.1) | 26 (38.2) | 0.001 |
Antithrombotic therapy | ||||
SAPT | 18 (17.1) | 3 (8.1) | 15 (22) | 0.115 |
DAPT | 66 (62.9) | 28 (75.7) | 38 (55.9) | 0.072 |
SAPT + OAC | 10 (9.5) | 3 (8.1) | 7 (10.3) | 0.999 |
Triple therapy | 11 (10.5) | 3 (8.1) | 8 (11.8) | 0.823 |
- Citation: Rondano E, Bertolazzi M, Galluzzo A, Maltese L, Caccianotti P, Macciò S, Mazza S, Di Ruocco MV, Favretto S, Occhetta E, Rametta F. Effectiveness and safety of antithrombotic strategies in elderly patients with acute myocardial infarction. World J Cardiol 2020; 12(11): 513-525
- URL: https://www.wjgnet.com/1949-8462/full/v12/i11/513.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i11.513